Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2020 third-quarter earnings
Lede-What You Need to Know About Johnson & Johnson's 2020 Third-Quarter Earnings.jpg

What you need to know about Johnson & Johnson’s 2020 third-quarter earnings

Check out this infographic breakdown of the company’s third-quarter 2020 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Inset - Quarterly Earnings Ribbon
2020 Q3 Earnings Infographic Johnson & Johnson

This morning, Johnson & Johnson shared its third-quarter performance.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.

“Johnson & Johnson’s solid third-quarter performance reflects the strength of our business model, the quality and breadth of our portfolio and our relentless drive toward innovation,” says Joseph Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson. “We continue to be driven by our purpose to advance health for humanity as we work to accelerate the development of a safe, effective and affordable investigational COVID-19 vaccine candidate on a not-for-profit basis for pandemic use. The results in these extraordinary times were made possible by our colleagues around the world and their unwavering resilience and focus to deliver value to all of our stakeholders by providing healthcare solutions that benefit people in need globally.”

For more details about the company’s 2020 third-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.